Cafepharma Today

June 9 2025 - Merck claims study success with PCSK9 cholesterol pill
Merck claims study success with PCSK9 cholesterol pill
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer
Drug imports plummeted in April despite tariff threat
Sanofi starts shipping RSV drug early as rival nears market
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Eli Lilly and Immunogen enter development deal for potential cancer treatments
Yahoo/AP
Tuesday, December 20, 2011 - 11:05am
tags:
Eli Lilly, Immunogen, Targeted Antibody Payload, cancer
Oncothyreon Files Investigational New Drug Application for ONT-10
Yahoo
Tuesday, December 20, 2011 - 11:04am
tags:
Oncothyreon, ONT-10, cancer, vaccines
What Can We Expect From CytRx In 2012?
Seeking Alpha
Tuesday, December 20, 2011 - 10:54am
tags:
CytRx, Bafetinib, INNO-206
Alexza And Somaxon: 2 Distressed Biotechs On Sale And Up For Sale
Seeking Alpha
Tuesday, December 20, 2011 - 10:51am
tags:
Somaxon, Alexza
AstraZeneca abandoning anti-ovarian cancer drug, warns antidepressant not testing well
Yahoo/AP
Tuesday, December 20, 2011 - 10:50am
tags:
antidepressants, Targacept, ovarian cancer, AstraZeneca, TC-5214, olaparib
Astra Zeneca Slides Towards the Patent Cliff
WSJ Online
Tuesday, December 20, 2011 - 10:33am
tags:
patents, AstraZeneca, Seroquel XR, Crestor
Lilly Has A 20% Downside; Pfizer Safer
Seeking Alpha
Tuesday, December 20, 2011 - 10:27am
tags:
Lilly, Pfizer, solanezumab
Targacept: What's Left After Latest TC-5214 Disappointment?
Seeking Alpha
Tuesday, December 20, 2011 - 10:25am
tags:
TC-5214, Targacept, AstraZeneca, depression
Sanofi Says MS Pill Aubagio Fails to Beat Rebif in Trial
Bloomberg
Tuesday, December 20, 2011 - 10:23am
tags:
Sanofi, MS, Aubagio, Rebif, multiple sclerosis, Merck KGaA
Teva Pursues First Type 1 Diabetes Treatment Since Insulin
Bloomberg
Monday, December 19, 2011 - 10:15pm
tags:
Teva Pharmaceuticals, type 1 diabetes, DiaPep277, Sanofi
Pharma Fraud Continues To Fill The US Treasury
Pharmalot
Monday, December 19, 2011 - 4:24pm
tags:
fraud, Merck Serono, Novo Nordisk, False Claims Act
Alexza layoffs looming
Fierce Pharma
Monday, December 19, 2011 - 4:08pm
tags:
layoffs, Alexa, Adasuve, Staccato
[video]4 Biotechs Dominating the Week
Motley Fool
Monday, December 19, 2011 - 4:06pm
tags:
YM BioSciences, BioSante, Pharmasset, Alexa
Amgen and Watson Announce Collaboration to Develop and Commercialize Oncology Biosimilars
Yahoo
Monday, December 19, 2011 - 4:04pm
tags:
Amgen, Watson, biosimilars, cancer, oncology
With new generic rivals, Lipitor's sales halved
Yahoo/AP
Monday, December 19, 2011 - 4:03pm
tags:
Pfizer, generics, Lipitor, statins
ARIAD's Prolific 2011
Motley Fool
Monday, December 19, 2011 - 4:02pm
tags:
Ariad Pharmaceuticals
FDA warning on Multaq emphasizes risks for patients with permanent heart irregularity
Yahoo/AP
Monday, December 19, 2011 - 4:01pm
tags:
FDA, Multaq, Sanofi
Trius reports on late-stage study for lead product
Yahoo/AP
Monday, December 19, 2011 - 4:01pm
tags:
Trius Therapeutics, Zyvox, Prizer, MRSA, tedizolid
Is YM the Next Incyte?
Minyanville
Monday, December 19, 2011 - 2:19pm
tags:
Incyte, YM BioSciences, CYT387, myelofibrosis
Somaxon to explore strategic options, cut jobs
Reuters
Monday, December 19, 2011 - 2:00pm
tags:
Somaxon, Silenor, layoffs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.